![Cyril Rocher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Cyril Rocher is currently the Managing Director at Proxipaca Finance SA since 2012.
Prior to his current position, he served as the Chief Executive Officer at Primaveris SAS from 2000 to 2011.
He also held the role of Managing Director at Proencia SA from 2011 to 2012.
Additionally, Mr. Rocher has experience as a Director at Pharmaxon SAS.
Postes actifs de Cyril Rocher
| Sociétés | Poste | Début |
|---|---|---|
Proxipaca Finance SA
 Proxipaca Finance SA Investment ManagersFinance Holding company | Directeur Général | - |
Anciens postes connus de Cyril Rocher
| Sociétés | Poste | Fin |
|---|---|---|
Pharmaxon SAS
 Pharmaxon SAS Pharmaceuticals: MajorHealth Technology Discovers, develops and markets therapeutic drugs controlling cell mobility | Directeur/Membre du Conseil | 18/12/2012 |
Proencia SA
 Proencia SA Investment ManagersFinance PROENCIA is an active manager which invested in small companies in all sectors of activity excluding trade, hotels and restaurants in the Provence/Alpes/Cote d'Azur region of France. The fund has been divesting since 2012. The firm seeked to invest EUR 50,000-100,000 in established companies (SA, SAS, SARL) which have their headquarters or operations in the Provence/Alpes/Cote d'Azur region and which are in the process of creation, development or transmission. They also provided funding of up to EUR 200,000 in a second round of financing. PROENCIA typically took minority stakes in their investee companies, partnering with management to increase value. Investee companies could benefit from coaching conducted by the l'Institut Régional à la Création d'entreprise in designing management tools as well as benefiting from PROXIPACA's network of contacts. The Investment Committee made the firm's investment decisions. The firm generally held an investment for five to six years. | President | 01/01/2012 |
Primaveris SAS
 Primaveris SAS Investment ManagersFinance PRIMAVERIS is an active manager which invests in innovative early-stage companies all areas of technology including ICT, life sciences, energy and environment. They invest in companies in the Provence/Alpes/Cote d'Azur region of France. The firm seeks to invest in newly-created companies (SA, SAS, SARL) with less than three years of age, which are based in or have operations in Provence/Alpes/Cote d'Azur and which are eligible for the 'partnership with public research' (Loi sur l'Innovation et La Recherche de juillet 1999) which facilitates transformation of research-based projects into businesses. PRIMAVERIS typically takes minority stakes in their investee companies, acting as sole investor or in syndication with other investors, investing between EUR 150,000-500,000 in the first round and EUR 500,000 in successive rounds. The firm's Investment Committee makes investment decisions. They generally hold an investment for five to six years to enable the company to develop the project and to establish solid foundations for growth. | President | 30/01/2011 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Proxipaca Finance SA
Proxipaca Finance SA Investment ManagersFinance Holding company | Finance |
Primaveris SAS
Primaveris SAS Investment ManagersFinance PRIMAVERIS is an active manager which invests in innovative early-stage companies all areas of technology including ICT, life sciences, energy and environment. They invest in companies in the Provence/Alpes/Cote d'Azur region of France. The firm seeks to invest in newly-created companies (SA, SAS, SARL) with less than three years of age, which are based in or have operations in Provence/Alpes/Cote d'Azur and which are eligible for the 'partnership with public research' (Loi sur l'Innovation et La Recherche de juillet 1999) which facilitates transformation of research-based projects into businesses. PRIMAVERIS typically takes minority stakes in their investee companies, acting as sole investor or in syndication with other investors, investing between EUR 150,000-500,000 in the first round and EUR 500,000 in successive rounds. The firm's Investment Committee makes investment decisions. They generally hold an investment for five to six years to enable the company to develop the project and to establish solid foundations for growth. | Finance |
Proencia SA
Proencia SA Investment ManagersFinance PROENCIA is an active manager which invested in small companies in all sectors of activity excluding trade, hotels and restaurants in the Provence/Alpes/Cote d'Azur region of France. The fund has been divesting since 2012. The firm seeked to invest EUR 50,000-100,000 in established companies (SA, SAS, SARL) which have their headquarters or operations in the Provence/Alpes/Cote d'Azur region and which are in the process of creation, development or transmission. They also provided funding of up to EUR 200,000 in a second round of financing. PROENCIA typically took minority stakes in their investee companies, partnering with management to increase value. Investee companies could benefit from coaching conducted by the l'Institut Régional à la Création d'entreprise in designing management tools as well as benefiting from PROXIPACA's network of contacts. The Investment Committee made the firm's investment decisions. The firm generally held an investment for five to six years. | Finance |
Pharmaxon SAS
Pharmaxon SAS Pharmaceuticals: MajorHealth Technology Discovers, develops and markets therapeutic drugs controlling cell mobility | Health Technology |
